tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CRSP Stock Latest News

Crispr Therapeutics Faces Stock Dip Amid Promising Developments
Weekend UpdatesCrispr Therapeutics Faces Stock Dip Amid Promising Developments
16m ago
CRSP
Cathie Wood Makes a $69M Bet on Exact Sciences; Sells Palantir, Roblox, and DraftKings
PremiumMarket News
Cathie Wood Makes a $69M Bet on Exact Sciences; Sells Palantir, Roblox, and DraftKings
16h ago
GH
ABNB
Crispr Therapeutics’ CTX112 Study: A New Frontier in Autoimmune Disease Treatment
PremiumCompany Announcements
Crispr Therapeutics’ CTX112 Study: A New Frontier in Autoimmune Disease Treatment
22h ago
CRSP
Crispr Therapeutics price target raised to $12 from $10 at Barclays
PremiumThe Fly
Crispr Therapeutics price target raised to $12 from $10 at Barclays
1d ago
CRSP
Cathie Wood ‘Buys the Dip’ in AMD Stock after Q2 Results, Cuts Roblox and Palantir (PLTR) Stakes
PremiumMarket News
Cathie Wood ‘Buys the Dip’ in AMD Stock after Q2 Results, Cuts Roblox and Palantir (PLTR) Stakes
2d ago
AMD
CRSP
Crispr Therapeutics AG: Strong Sales Growth and Global Expansion Justify Buy Rating
PremiumRatingsCrispr Therapeutics AG: Strong Sales Growth and Global Expansion Justify Buy Rating
2d ago
CRSP
CRSP, TWST: Cathie Wood Bets Millions on Biotech, Continues Dumping Roblox
Premium
Market News
CRSP, TWST: Cathie Wood Bets Millions on Biotech, Continues Dumping Roblox
3d ago
XYZ
ARKG
Crispr Therapeutics’ CTX112 Study: A Promising Step in Autoimmune Disease Treatment
Premium
Company Announcements
Crispr Therapeutics’ CTX112 Study: A Promising Step in Autoimmune Disease Treatment
3d ago
CRSP
Cathie Wood’s ARK Investment buys 181.3K shares of Crispr Therapeutics today
PremiumThe Fly
Cathie Wood’s ARK Investment buys 181.3K shares of Crispr Therapeutics today
4d ago
CRSP
Crispr Therapeutics AG: Strong Financial Foundation and Promising Pipeline Amidst Strategic Growth
PremiumRatings
Crispr Therapeutics AG: Strong Financial Foundation and Promising Pipeline Amidst Strategic Growth
4d ago
CRSP
Crispr Therapeutics AG: Promising Growth and Expanding Pipeline Justify Buy Rating
PremiumRatings
Crispr Therapeutics AG: Promising Growth and Expanding Pipeline Justify Buy Rating
4d ago
CRSP
CRISPR Therapeutics Reports Q2 2025 Progress and Financials
PremiumCompany Announcements
CRISPR Therapeutics Reports Q2 2025 Progress and Financials
4d ago
CRSP
Cautious Hold Rating for Casgevy Amid Growth and Upcoming Data Releases
PremiumRatingsCautious Hold Rating for Casgevy Amid Growth and Upcoming Data Releases
5d ago
CRSP
Closing Bell Movers: Palantir hits record highs on beat and raise
Premium
The Fly
Closing Bell Movers: Palantir hits record highs on beat and raise
5d ago
AL
KD
Crispr Therapeutics reports Q2 EPS ($2.40), consensus ($1.40)
Premium
The Fly
Crispr Therapeutics reports Q2 EPS ($2.40), consensus ($1.40)
5d ago
CRSP
Cathie Wood Buys $69M Worth of Figma Stock on Blockbuster IPO Debut
PremiumMarket News
Cathie Wood Buys $69M Worth of Figma Stock on Blockbuster IPO Debut
8d ago
PD
AMD
CRSP, ABSI, IRDM: Cathie Wood Offloads $16.4M of CRISPR Therapeutics Stock, Buys Absci and Iridium
PremiumMarket News
CRSP, ABSI, IRDM: Cathie Wood Offloads $16.4M of CRISPR Therapeutics Stock, Buys Absci and Iridium
12d ago
ABSI
ARKG
Insiders Are Betting Big on These 2 Stocks – Should You Follow Their Lead?
PremiumStock Analysis & Ideas
Insiders Are Betting Big on These 2 Stocks – Should You Follow Their Lead?
17d ago
ELV
CRSP
Crispr Therapeutics price target lowered to $78 from $79 at BofA
PremiumThe Fly
Crispr Therapeutics price target lowered to $78 from $79 at BofA
18d ago
CRSP
CRISPR Stock (CRSP) Continues to Sizzle on Insider Deal
PremiumMarket NewsCRISPR Stock (CRSP) Continues to Sizzle on Insider Deal
19d ago
CRSP
Crispr Therapeutics AG Stock Soars Amid Insider Confidence
Premium
Weekend Updates
Crispr Therapeutics AG Stock Soars Amid Insider Confidence
21d ago
CRSP
CRISPR Therapeutics (CRSP) Surges after Director Buys over $51M Worth of Shares
Premium
Market News
CRISPR Therapeutics (CRSP) Surges after Director Buys over $51M Worth of Shares
22d ago
CRSP

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >